Literature DB >> 18618164

Healing patterns of critical size bony defects in rat following bone graft.

N Mokbel1, C Bou Serhal, G Matni, N Naaman.   

Abstract

PURPOSE: The aim of the present study was to evaluate the healing patterns of critical size calvarial bony defects treated with different bone substitutes and to compare them to an autogenous graft and an ungrafted control group.
MATERIALS AND METHODS: Thirty-six Sprague-Dawley rats (200-230 g) were used. A periosteal flap was raised and an 8 mm defect was trephined. Rats were divided into six groups and treated as follows: group 1 was treated with a deproteinized bovine xenograft (XO), group 2 was treated with a bovine xenograft and covered with a resorbable membrane (XOCM), defects in group 3 were filled with a decalcified freeze-dried bone allograft (DFDBA), group 4 was treated with a composite bone substitute made of bovine xenograft and collagen (XOC), group 5 was filled with autogenous bone (AUTO), and group 6 was left untreated (control). The animals were euthanized at 2 months.
RESULTS: Mean bone formation was 2.97 +/- 1.82 mm2 in group 5 (AUTO) followed by 2.93 +/- 1.93 mm2 in group 3 (DFDBA) and 2.25 +/- 1.94 mm2 in group 4 (XOC). Groups 1, 2, and 6 (XO, XOCM, and control, respectively) were not significantly different (p > 0.05) with a mean bone formation of 1.97 +/- 1.64, 1.87 +/- 1.07, and 1.85 +/- 1.04 mm2, respectively.
CONCLUSIONS: This work confirmed the superiority of autogenous bone when it comes to bone grafting. Nevertheless, some bone substitutes can improve bone formation when compared to the control. New bone substitutes with growth factors to improve their abilities to induce bone formation should be experimented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18618164     DOI: 10.1007/s10006-008-0107-7

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  28 in total

1.  Bone graft substitutes: a comparative qualitative histologic review of current osteoconductive grafting materials.

Authors:  K A Al Ruhaimi
Journal:  Int J Oral Maxillofac Implants       Date:  2001 Jan-Feb       Impact factor: 2.804

2.  Increased Tgf-beta1 production by rat osteoblasts in the presence of PepGen P-15 in vitro.

Authors:  Candice Trasatti; Robert Spears; James L Gutmann; Lynne A Opperman
Journal:  J Endod       Date:  2004-04       Impact factor: 4.171

3.  The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects.

Authors:  K Takagi; M R Urist
Journal:  Clin Orthop Relat Res       Date:  1982 Nov-Dec       Impact factor: 4.176

4.  New advances in bone research.

Authors:  H C Amstutz; E E Johnson; G A Finerman; R A Meals; J R Moreland; W C Kim; M R Urist
Journal:  West J Med       Date:  1984-07

5.  Effect of a hydroxyapatite tricalcium phosphate alloplast on osseous repair in the rat calvarium.

Authors:  Kurt B Fleckenstein; Michael F Cuenin; Mark E Peacock; Michael A Billman; Gary D Swiec; Thomas B Buxton; Baldev B Singh; James C McPherson
Journal:  J Periodontol       Date:  2006-01       Impact factor: 6.993

6.  Characterization of osteoblast-like behavior of cultured bone marrow stromal cells on various polymer surfaces.

Authors:  J W Calvert; K G Marra; L Cook; P N Kumta; P A DiMilla; L E Weiss
Journal:  J Biomed Mater Res       Date:  2000-11

7.  Clinical evaluation of Bio-Oss: a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.

Authors:  C R Richardson; J T Mellonig; M A Brunsvold; H T McDonnell; D L Cochran
Journal:  J Clin Periodontol       Date:  1999-07       Impact factor: 8.728

8.  Clinical and histologic observations of sites implanted with intraoral autologous bone grafts or allografts. 15 human case reports.

Authors:  W Becker; M Urist; B E Becker; W Jackson; D A Parry; M Bartold; G Vincenzzi; D De Georges; M Niederwanger
Journal:  J Periodontol       Date:  1996-10       Impact factor: 6.993

9.  Enhancement of osteoblast proliferation in vitro by selective enrichment of demineralized freeze-dried bone allograft with specific growth factors.

Authors:  David A Mott; Jason Mailhot; Michael F Cuenin; Mohamed Sharawy; James Borke
Journal:  J Oral Implantol       Date:  2002       Impact factor: 1.779

10.  Cortical bone regeneration with a synthetic cell-binding peptide: a histologic and histomorphometric pilot study.

Authors:  Antonio Scarano; Giovanna Iezzi; Giovanna Petrone; Giovanna Orsini; Marco Degidi; Rita Strocchi; Adriand Piattelli
Journal:  Implant Dent       Date:  2003       Impact factor: 2.454

View more
  15 in total

1.  Extremely small-magnitude accelerations enhance bone regeneration: a preliminary study.

Authors:  Soon Jung Hwang; Svetlana Lublinsky; Young-Kwon Seo; In Sook Kim; Stefan Judex
Journal:  Clin Orthop Relat Res       Date:  2008-10-15       Impact factor: 4.176

2.  Local delivery of FTY720 accelerates cranial allograft incorporation and bone formation.

Authors:  Cynthia Huang; Anusuya Das; Daniel Barker; Sunil Tholpady; Tiffany Wang; Quanjun Cui; Roy Ogle; Edward Botchwey
Journal:  Cell Tissue Res       Date:  2011-08-24       Impact factor: 5.249

3.  Local delivery of rhVEGF165 through biocoated nHA/coral block grafts in critical-sized dog mandible defects: a histological study at the early stages of bone healing.

Authors:  Bing Du; Yao Gao; Yue Deng; Yadong Zhao; Chunhua Lai; Zehong Guo; Mingdeng Rong; Lei Zhou
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 4.  Open versus closed reduction: comminuted mandibular fractures.

Authors:  Bruno Ramos Chrcanovic
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

5.  Tissue-engineered composite scaffold of poly(lactide-co-glycolide) and hydroxyapatite nanoparticles seeded with autologous mesenchymal stem cells for bone regeneration.

Authors:  Bing Zhang; Pei-Biao Zhang; Zong-Liang Wang; Zhong-Wen Lyu; Han Wu
Journal:  J Zhejiang Univ Sci B       Date:  2017 Nov.       Impact factor: 3.066

6.  Angiogenesis and bone regeneration of porous nano-hydroxyapatite/coralline blocks coated with rhVEGF165 in critical-size alveolar bone defects in vivo.

Authors:  Bing Du; Weizhen Liu; Yue Deng; Shaobing Li; Xiangning Liu; Yan Gao; Lei Zhou
Journal:  Int J Nanomedicine       Date:  2015-03-31

7.  Various Dosages of BMP-2 for Management of Massive Bone Defect in Sprague Dawley Rat.

Authors:  Achmad Fauzi Kamal; Othdeh Samuel Halomoan Siahaan; Jessica Fiolin
Journal:  Arch Bone Jt Surg       Date:  2019-11

8.  In vivo behaviour of a biodegradable poly(trimethylene carbonate) barrier membrane: a histological study in rats.

Authors:  A C Van Leeuwen; T G Van Kooten; D W Grijpma; R R M Bos
Journal:  J Mater Sci Mater Med       Date:  2012-05-09       Impact factor: 3.896

9.  Enhancing the bioactivity of Poly(lactic-co-glycolic acid) scaffold with a nano-hydroxyapatite coating for the treatment of segmental bone defect in a rabbit model.

Authors:  De-Xin Wang; Yao He; Long Bi; Ze-Hua Qu; Ji-Wei Zou; Zhen Pan; Jun-Jun Fan; Liang Chen; Xin Dong; Xiang-Nan Liu; Guo-Xian Pei; Jian-Dong Ding
Journal:  Int J Nanomedicine       Date:  2013-05-09

10.  Is bone transplantation the gold standard for repair of alveolar bone defects?

Authors:  Cassio Eduardo Raposo-Amaral; Daniela Franco Bueno; Ana Beatriz Almeida; Vanda Jorgetti; Cristiane Cabral Costa; Cecília Helena Gouveia; Luiz Carlos Vulcano; Roberto D Fanganiello; Maria Rita Passos-Bueno; Nivaldo Alonso
Journal:  J Tissue Eng       Date:  2014-01-16       Impact factor: 7.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.